Becton, Dickinson and Company (BD) has globally introduced the new automated instrument, the BD FACSDuet Premium Sample Preparation System, for cellular diagnostic applications.

Asep Medical has entered a definitive agreement with Seaspring for sepsis diagnosis technology Sepset.

Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”) is pleased to announce that our flagship comprehensive genomic profiling (CGP) product, OncoScreenTM Plus, was featured in a phase 3 multi-regional clinical trial (MRCT), along with FoundationOneCDx, in support of advancement in breast cancer treatment.

A blood test identified patients with a treatable neurometabolic disease in a prospective trial, suggesting that it can be used to improve diagnosis of a condition that is currently detected using an invasive procedure.

The first diagnostic test for long COVID is now available to patients across Australia. The test can help physicians diagnose long COVID by differentiating it from other diseases with similar symptoms, and to design personalized treatment approaches.

Revvity, Inc., today reported financial results for the first quarter ended April 2, 2023.

Siemens Healthineers AG today announces its results for the second quarter, ending March 31, of fiscal year 2023.

On the evening of April 25, BGI Genomics released its first quarterly financial results for 2023.

As expected, significantly lower demand for COVID-19 tests leads to a decrease in Group sales (-3%1 at constant exchange rates [CER] and -7% in Swiss francs); excluding this effect, Group sales grow 8%.

Thermo Fisher Scientific Inc., the world leader in serving science, today reported its financial results for the first quarter ended April 1, 2023.